PACS Group
PACS
43.19
+0.38
+0.89%
PACS Group
US · PACS
#1809 by market cap
Listed 2024
43.19
+0.38
+0.89%
Live - 5344 symbols - heartbeat 359s ago
· 2026-10-08 05:18
Pre-market
43.00
-0.44%
After-hours
42.42
-1.79%
- Market cap
- 6.84B
- P/E (TTM)i
- 25.26
- P/Bi
- 6.16
- EPSi
- 1.22
- Div yieldi
- 0.00%
- 52W posi
- 84%
Reader sentiment
Are you bullish or bearish on PACS?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.11, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 5 years
Latest year +29.32% YoY
Margins
- Gross margin
- 14.75%
- Operating margin
- 5.85%
- Net margin
- 3.62%
Key ratios & quality
- Enterprise valuei
- 7.17B
- PEG ratioi
- 3.02
- Altman Z-Scorei
- 2.11
PEG uses trailing P/E against the 3-year net income growth rate (8.37%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1.17B | 2.42B | 3.11B | 4.09B | 5.29B |
| Gross profit | 187.35M | 400.68M | 447.07M | 507.69M | 780.33M |
| Selling & admin expenses | 96.83M | 149.01M | 213.66M | 343.81M | 415.07M |
| Research & development | -- | -- | -- | -- | -- |
| Operating profit | 83.36M | 229.36M | 207.77M | 123.07M | 309.60M |
| Pretax profit | 81.43M | 207.05M | 157.32M | 101.55M | 284.45M |
| Tax | 33.48M | 56.55M | 44.44M | 46.21M | 92.99M |
| Net profit | 47.95M | 150.50M | 112.88M | 55.34M | 191.46M |
| Basic EPS | 0 | 1 | 1 | 0 | 1 |
| Diluted EPS | 0.32 | 1.00 | 0.76 | 0.38 | 1.22 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 1.28B | 1.31B | 1.34B | 1.36B | 1.42B | 1.43B |
| Gross profit | 159.56M | 194.01M | 203.20M | 223.56M | 250.43M | 243.76M |
| Selling & admin expenses | 98.72M | 100.33M | 102.53M | 113.49M | 112.32M | 114.31M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 48.14M | 80.50M | 86.27M | 94.69M | 120.04M | 109.33M |
| Pretax profit | 42.73M | 78.61M | 76.30M | 86.81M | 113.74M | 105.84M |
| Tax | 14.35M | 27.65M | 23.97M | 27.03M | 33.07M | 29.49M |
| Net profit | 28.38M | 50.97M | 52.33M | 59.79M | 80.67M | 76.35M |
| Basic EPS | 0 | 0 | 0 | 0 | 1 | 0 |
| Diluted EPS | 0.17 | 0.31 | 0.32 | 0.39 | 0.50 | 0.47 |
Balance sheet
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total current assets | -- | 511.16M | 722.15M | 938.26M | 1.07B |
| Cash & ST investments | -- | 58.27M | 73.42M | 157.67M | 197.02M |
| Inventory | -- | -- | -- | -- | -- |
| Total assets | -- | 2.46B | 3.51B | 5.24B | 5.58B |
| Total current liabilities | -- | 483.86M | 456.93M | 978.43M | 1.00B |
| Short-term debt | -- | 182.43M | 127.20M | 314.26M | 186.46M |
| Long-term debt | -- | 438.34M | 715.71M | 250.98M | 344.80M |
| Total liabilities | -- | 2,393,240,000.00 | 3,411,013,000.00 | 4,527,218,000.00 | 4,631,585,000.00 |
| Total equity | -- | 68.65M | 101.73M | 715.69M | 952.45M |
| Retained earnings | -- | 63.52M | 96.00M | 118.04M | 309.58M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.08B | 1.08B | 1.13B | 1.07B | 1.07B | 962.35M |
| Cash & ST investments | 287.51M | 294.17M | 355.67M | 197.02M | 247.98M | 164.45M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 5.49B | 5.50B | 5.63B | 5.58B | 5.66B | 5.66B |
| Total current liabilities | 1.11B | 1.17B | 1.20B | 1.00B | 1.07B | 1.06B |
| Short-term debt | 296.58M | 297.19M | 258.13M | 186.46M | 192.27M | 163.44M |
| Long-term debt | 249.09M | 246.99M | 245.90M | 344.80M | 284.81M | 238.71M |
| Total liabilities | 4,738,127,000.00 | 4,689,501,000.00 | 4,749,976,000.00 | 4,631,585,000.00 | 4,621,328,000.00 | 4,540,921,000.00 |
| Total equity | 756.27M | 812.67M | 876.92M | 952.45M | 1.04B | 1.12B |
| Retained earnings | 146.51M | 197.47M | 249.88M | 309.58M | 390.27M | 466.64M |
Cash flow
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating cash flow | 57.60M | 92.62M | 63.70M | 367.34M | 404.22M |
| Depreciation & amortization | 7.15M | 22.31M | 25.63M | 40.81M | 55.66M |
| Free cash flow | -146.16M | 14.38M | -109.11M | 17.53M | 155.07M |
| Dividends paid | -53.80M | -60.28M | -80.39M | -33.72M | 0 |
| Stock buybacks / issuance | -- | 0 | 0 | 509.44M | 0 |
| Ending cash balance | 68.56M | 98.21M | 118.70M | 160.84M | 232.05M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 150.24M | 52.57M | 204.80M | -3.39M | 236.34M | 135.51M |
| Depreciation & amortization | 12.71M | 13.18M | 14.40M | 15.38M | 18.08M | 20.12M |
| Free cash flow | 132.53M | 33.76M | 106.44M | -117.65M | 127.99M | 4.70M |
| Dividends paid | -- | -- | -- | 0 | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | 0 | -- | -- |
| Ending cash balance | 290.61M | 297.64M | 359.06M | 232.05M | 273.71M | 176.91M |
Returns & efficiency
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| ROE %i | -- | 236.46 | 141.29 | 13.84 | 23.13 |
| ROA %i | -- | 6.11 | 3.78 | 1.27 | 3.54 |
| ROIC %i | -- | 8.50 | 6.08 | 2.55 | 4.88 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- |
| EBIT margin %i | 7.43 | 9.60 | 6.66 | 3.57 | 5.91 |
| FCF / sales %i | -- | 0.59 | -- | 0.43 | 2.93 |
| Current ratioi | -- | 1.06 | 1.58 | 0.96 | 1.07 |
| Quick ratioi | -- | 0.99 | 1.47 | 0.89 | 0.90 |
| Debt / assetsi | -- | 78.21 | 79.85 | 66.78 | 62.16 |
| LT debt / equityi | -- | 2,738.78 | 2,785.62 | 449.12 | 346.93 |
| Interest coveragei | 16.43 | 9.11 | 4.15 | 3.29 | 11.03 |
| Revenue CAGR (3Y) %i | -- | -- | -- | 51.91 | 29.74 |
| Net income CAGR (3Y) %i | -- | -- | -- | 5.16 | 8.37 |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | 120.94 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 11.25 | 19.18 | 22.08 | 23.13 | 27.28 | 28.08 |
| ROA %i | 1.06 | 2.81 | 3.33 | 3.54 | 4.37 | 4.82 |
| ROIC %i | 2.07 | 3.96 | 4.76 | 4.88 | 6.03 | 6.66 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 2.74 | 5.10 | 5.60 | 5.91 | 7.06 | 7.43 |
| FCF / sales %i | 4.06 | 6.04 | 4.95 | 2.93 | 2.77 | 2.19 |
| Current ratioi | 0.98 | 0.92 | 0.94 | 1.07 | 0.99 | 0.91 |
| Quick ratioi | 0.93 | 0.84 | 0.88 | 0.90 | 0.91 | 0.84 |
| Debt / assetsi | 64.97 | 64.26 | 61.62 | 62.16 | 59.42 | 57.48 |
| LT debt / equityi | 436.30 | 401.37 | 368.28 | 346.93 | 305.94 | 278.06 |
| Interest coveragei | 3.46 | 8.31 | 9.90 | 11.03 | 13.75 | 13.94 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-10-08 05:18:54 · For reference only, not investment advice and not tailored to your situation.